22Jan
Healthcare Antitrust – What to Expect in 2021
The year 2020 was an eventful one in the world of healthcare antitrust. The year began with the announcement of the precedent-setting settlement of the California Attorney General’s action against Sutter Health and ended with the settlement of multi-district antitrust litigation against the Blue Cross Blue Shield Association (and its member Blues)....
By:
Akerman LLP - Health Law Rx
Related
In MV Transportation, Inc., a 3 to 1 majority of the National Labor Relations Board recently abandon...
Read More >
New York’s recently enacted Stop Hacks and Improve Electronic Data Security Act (SHIELD Act) enhanc...
Read More >
States Impose Sexual Harassment Policy & Training Requirements - In the wake of the #MeToo Movement...
Read More >
In re: Essendant, Inc. Stockholder Litigation, C.A. No. 2018-0789-JRS (Del. Ch. Dec. 30, 2019). Whe...
Read More >
As COVID-19 has proliferated throughout the United States, the resulting health-related government a...
Read More >
The U.S. Chemical Safety and Hazard Investigation Board (CSB) adopted regulations on February 21, 20...
Read More >